Craig Jamieson earned his B.Sc. (Hons) in Chemistry at the University of Glasgow in 1996. He pursued his Ph.D. studies under Professor R Ramage at the University of Edinburgh (1999). Following postdoctoral research under the supervision of Professor S V Ley at the University of Cambridge, in 2001 he was appointed as a Principal Scientist in GlaxoSmithKline's Discovery Medicinal Chemistry group, working on a range of exploratory medicinal chemistry programmes. In 2004, Dr Jamieson joined Organon Laboratories (later Merck Research Labs) as a Group Leader in the Medicinal Chemistry Department, with responsibility for hit to clinical candidate optimisation. In August 2010, he was appointed as a John Anderson Research Lecturer in Chemical Biology, based in the Department of Pure and Applied Chemistry at the University of Strathclyde.Keith Livingstone completed his M.Chem in Chemistry with Drug Discovery at the University of Strathclyde (2016) under the supervision of Dr Craig Jamieson. Keith remained at Strathclyde and is currently in the final year of his doctoral studies with Dr Jamieson, which have also included two short research secondments at GlaxoSmithKline Medicines Research Centre Stevenage, and with Prof Ryan Gilmour at the Westfälische Wilhelms-Universität Münster.